Trialect

+ More Filters

Reset Filters

Specialty

Funding Organization

Funding Type

Eligible Country

Deadline

From

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Bridge Award

American Association for the Study of Liver Diseases

The AASLD Foundation Bridge Award supports investigators who have recently submitted an NIH R or other federally funded equivalent award and have received competitive scores on their proposal, but were not funded, as they strengthen their proposal for resubmission to the NIH or other federal agency.

Additional dedicated funding to advance research activities in autoimmune hepatitis is available for the 2025 Awards cycle. Applications in autoimmune hepatitis are encouraged in all early to mid-career research award categories and the Pilot and Autoimmune Exploratory Research Award categories.

Application Deadline: Jan. 15, 2025

Specialties

Medical

Medical - Clinical Science

Medical - Basic Science

Medical - Translational

Eligibility Requirements

In order to be eligible for this award, the applicant must adhere to the following guidelines:

The applicant must:
- Have a faculty appointment at or below the rank of Associate Professor.
- Be a member of the American Association for the Study of Liver Diseases (AASLD) at the time of award application and maintain active membership for the duration of the award period.
- Be able to devote at least 20% effort to the research project on which this application is based.
- Be sponsored by a public or private non-profit institution accredited in the United States, Canada or Mexico engaged in health care and health-related research. Individuals employed at the NIH, FDA, and CDC are not eligible to apply.
- Have submitted their highly scored NIH R or other federal equivalent application within the last 18 months as of the application deadline (eligibility window starts on the date your application was reviewed by the NIH/federal equivalent study section). The applicant must be able to provide their Summary Statements and their submitted award materials on Standard Forms SF424 (R&R).
- Not currently hold a federally funded non-mentored grant (e.g., R01, P01, VA Merit) and not hold such a grant during the award period.
- Not hold other significant extramural mentored or non-mentored research funding (greater than $50,000) during the award period. Institutional funding and/or pilot research funding may be held during the award term.
The proposed project must:
- Be conducted at the sponsoring institution within the United States, Canada or Mexico.
Application limits:
- There is no restriction on the number of applicants an institution can sponsor each cycle, but only one applicant may be funded per distinct department within each institution in this award category.
- Applicants may only apply for one AASLD Foundation research award per calendar year

Sponsor Details

Sponsor Institute/Organizations: American Association for the Study of Liver Diseases

Address: 1001 North Fairfax Street 4th floor Alexandria, Virginia 22314

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity